Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone, Carboplatin, and Gemcitabine for Breast and Ovarian Cancer
NCT02046421Phase 1Completed
- Sponsor
- University of Chicago
- Start
- Nov 2013
- Primary completion
- May 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of mifepristone in breast cancer, ovarian epithelial cancer, fallopian tube cancer (PFTC) and 1 more, sponsored by University of Chicago. Started Nov 2013; status: completed.
02
Drugs
mifepristone
03
Conditions
breast cancerovarian epithelial cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT02046421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02046421.